ABOUT US
SCIENTIFIC ADVISORY BOARD
John Climax, PhD (SAB Chairman) is a founder and the current Executive Chairman of ICON Clinical Research plc, and a non-executive director of Amarin Corporation plc. He has over 25 years of experience in the contract research industry globally. Dr. Climax received his primary degree in pharmacy in 1977 from the University of Singapore, his masters in applied pharmacology in 1979 from the University of Wales and his PhD in clinical pharmacology from the National University of Ireland in 1982. He has authored a significant number of papers and presentations. Dr. Climax is an adjunct Professor at the Royal College of Surgeons, Dublin and Chairman of the Human Dignity Foundation, a Swiss based charity.Jan Wallace, MD trained in Neurology at Yale and remained on the staff there and at the VA Medical Center in charge of the Yale-VA Stroke Treatment Center for many years. He has more than 20 years experience in drug development encompassing Warner-Lambert/Parke-Davis and biotech start-ups including Athena Neurosciences where he was responsible for clinical and regulatory affairs. He has played a fundamental role in the development and approval of many new pharmaceuticals in the CNS area.
Reid Patterson, PhD was formerly Vice President of Drug Safety/Preclinical Safety at Abbott Laboratories, where his responsibilities included toxicology, pathology, comparative medicine, metabolism, pharmacokinetics, analytical chemistry, and drug analysis. He has extensive experience across a broad range of therapeutic areas, has contributed to over 25 successful New Drug Applications, and has been a regular contributor to meetings with regulatory authorities in the United States, Europe and Japan.
Mark W. Pierce, MD, PhD graduated from Northwestern University Medical School in Chicago and received his postgraduate training in internal medicine at The Peter Bent Brigham Hospital and Massachusetts General Hospital in Boston. Subsequently, he was Senior Vice President of Clinical Research at Pfizer, after directing clinical development at Abbott Laboratories and Warner Lambert Company.
Dr. Mehar Manku, Vice President of Research and Development and Dr. Anthony Clarke, Vice President, Clinical Development, both executive officers of Amarin, are also members of Amarin’s SAB.
